Read more

November 03, 2022
1 min read
Save

Speaker: Anti-science surfaces as a threat to nephrology, all health care specialties

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ORLANDO — As COVID-19 continues, drivers of current and potential pandemics are poverty, war, political instability, urbanization, deforestation, climate change and now anti-science, a presenter at ASN Kidney Week said.

In the keynote presentation, Peter J. Hotez, MD, PhD, dean of the National School of Tropical Medicine and a professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine, explored the ways anti-science activism impacts health care.

Quote from Peter Hotez, MD, PhD

For the first time, the WHO reported a decline in vaccinations around the globe in 2021, and Hotez said additional deaths occurred in the United States because many Americans refused to receive the COVID-19 vaccines.

Anti-science activism is taking on health care as a whole, Hotez said. He said medical professionals are finding themselves in a position where they must acknowledge politics for the first time.

“How do we uncouple [conservatism] from the anti-science? Because it’s killing more Americans than gun violence, global terrorism, nuclear proliferation [and] cyber-attacks and yet, we don’t frame it as such,” he said.

In a panel discussion following the keynote presentation, Hotez said communication with the public is an obstacle to combating anti-science. Therefore, it can also be part of the solution. Federal officials in the United States tend to communicate to the public in language that is on a fourth- or sixth-grade level and, according to Hotez, this can lead to mistrust.

Further, Hotez said nephrologists and health care professionals are often silent when faced with anti-science activism to protect the reputation of their institutions.

“We don't train physicians and scientists to talk to people at a macro level,” Hotez said. “I had to learn it through trial and error, more error than trial, and I'm still learning. But there is a way to do it, and I think if we start offering those public engagement options in our medical school training and fellowship training, then I think we can start doing that.”